Evidence map›Paper›PMID 36046709›Full record

ArticlePragmatic and observational research2022

Detection of Short-Term Side Effects of ChAdOx1 nCoV-19 Vaccine: A Cross-Sectional Study in a War-Torn Country.

Mohammed Alshakka, Najmaddin A H Hatem, Wafa Badullah, Rabab Alsakaf, Ali Rageh, Seena Abdulla Yousef, Mohamed Izham Mohamed Ibrahim

Abstract read
In one paragraph

Article in Pragmatic and observational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammed Alshakka *Section of Clinical Pharmacy, Faculty of Pharmacy, Aden University, Aden, Yemen.
Najmaddin A H HatemDepartment of Pharmacy Practice, College of Clinical Pharmacy, Hodeidah University, Alhodeidah, Yemen.ORCID 0000-0002-1028-7952
Wafa BadullahDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Aden University, Aden, Yemen.ORCID 0000-0003-1145-860X
Rabab AlsakafDepartment of Post-Marketing Surveillance, National Pharmacovigilance Center, Supreme Board of Drugs and Medical Appliances, Aden, Yemen.
Ali RagehSection of Clinical Pharmacy, Faculty of Pharmacy, Aden University, Aden, Yemen.
Seena Abdulla YousefDepartment of Community Medicine and Public Health, Faculty of Medicine and Health Sciences, Aden University, Aden, Yemen.
Mohamed Izham Mohamed IbrahimDepartment of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.ORCID 0000-0001-9757-3574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The chAdOx1 nCoV-19 vaccine is the first COVID-19 vaccine available in Yemen. Hence, this local-based study was used to identify the type and frequency of short-term side effects following 48 hours of the first shot of the vaccine. Methods: A cross-section of vaccinated participants in Aden were surveyed by telephone. Descriptive statistics were used for statistical analysis. Results: A total of 500 participants were included through convenient sampling. 27% of them were health care providers. Nearly 70% of the respondent experienced side effects. The top three side effects reported were fever (n=276, 55.2%), myalgia (n=270, 54%) and fatigue (n=247, 49.4%). Generally, most participants stated that they experienced the side effects after the first 24 hours of vaccination. Conclusion: Side effects that participants experienced were not different from the literature, indicating a safe profile for the vaccine. Further studies are needed to identify the side effects after the second and third dose of the vaccine. In addition, more studies are required to assess the efficacy of the existing vaccines against new variants.

Indexed as

COVID 19pharmacovigilancesafetyside-effectsvaccine hesitancy

Identifiers

PMID36046709
PMCPMC9423103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.